REDMILE GROUP, LLC Fate Therapeutics, Inc. Transaction History

REDMILE GROUP, LLC portfolio value:

$290.37M
portfolio value

REDMILE GROUP, LLC quarter portfolio value change:

-9.56%
quarter

Fate Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -30.70M $22.41 12.95M
Q2 2022 share 0.00% 0 shares -181.27M $24.78 12.95M
Q1 2022 share 0.00% 0 shares -255.77M $38.77 12.95M
Q4 2021 share 0.00% 0 shares -9.84M $60.07 12.95M
Q3 2021 share 0.00% 0 shares -356.58M $59.27 12.95M
Q2 2021 share 0.00% 0 shares 56.23M $86.79 12.95M
Q1 2021 share Increase +2.59% 327.48K shares -80.09M $82.45 12.95M
Q4 2020 share 0.00% 0 shares 643.61M $90.93 12.62M
Q3 2020 share 0.00% 0 shares 71.48M $39.97 12.62M
Q2 2020 share Increase +12.60% 1.41M shares 184.20M $34.31 12.62M
Q1 2020 share 0.00% 0 shares 29.61M $22.21 11.21M
Q4 2019 share 0.00% 0 shares 45.31M $19.57 11.21M
Q3 2019 share Increase +8.27% 857.14K shares -36.10M $15.53 11.21M
Q2 2019 share 0.00% 0 shares 28.28M $20.3 10.35M
Q1 2019 share 0.00% 0 shares 49.10M $17.57 10.35M
Q4 2018 share 0.00% 0 shares -35.84M $12.83 10.35M
Q3 2018 share Increase +55.64% 3.70M shares 93.28M $16.29 10.35M
Q2 2018 share 0.00% 0 shares 10.51M $11.34 6.65M
Q1 2018 share Increase +21.78% 1.19M shares 31.56M $9.76 6.65M
Q4 2017 share Increase +285.15% 4.04M shares 27.77M $6.11 5.46M
Q3 2017 share 0.00% 0 shares 1.02M $3.96 1.41M
Q2 2017 share 0.00% 0 shares -1.85M $3.24 1.41M
Q1 2017 share 0.00% 0 shares 2.89M $4.55 1.41M
Q4 2016 share Decrease -0.43% -6.1K shares -884K $2.51 1.41M
Q3 2016 share Decrease -5.13% -77.02K shares 1.89M $3.12 1.42M
Q2 2016 share Increase +1.02% 15.2K shares -123K $1.7 1.50M
Q1 2016 share Decrease -37.28% -884.02K shares -5.31M $1.8 1.48M